We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Paper-Based TB Test Could Increase Diagnoses Worldwide

By LabMedica International staff writers
Posted on 26 Sep 2017
Print article
Image: Scientists have developed a rapid, paper-based TB text that allows results to be read with a smartphone (Photo courtesy of Wikimedia Commons).
Image: Scientists have developed a rapid, paper-based TB text that allows results to be read with a smartphone (Photo courtesy of Wikimedia Commons).
In resource-limited areas, equipment requirements and long wait times for results are obstacles to early diagnosis and treatment of tuberculosis (TB). To tackle this problem, scientists have developed a rapid colorimetric TB assay using gold nanoparticles on a paper-based device than enables results to be read with a smartphone.

Most of deaths from TB occur in low- and middle-income countries and remote areas. Conventional methods such as sputum smear microscopy, chest X-rays, and molecular-based tests require equipment, electricity, and specialized personnel. So lead researcher Chien-Fu Chen, professor at National Taiwan University (Taiwan), and colleagues from Chang Gung Memorial Hospital (Taiwan) and elsewhere in Taiwan, set out to come up with a more practical diagnostic test that can be read with a smartphone, a technology that is becoming increasingly available in emerging economies.

The researchers combined gold nanoparticles with single-stranded DNA (ssDNA) sequences that bind to the genetic material of Mycobacterium tuberculosis. These nanoparticles were then incorporated into a paper-based device. Adding even a minute amount of lab-derived, double-stranded DNA (dsDNS) from M. tuberculosis changed the color of the test spots within an hour. Furthermore, multiple tests could be performed simultaneously with a 60 min turnaround time.

A smartphone camera was used to analyze the color change to determine the bacterial concentration. The researchers also tested a tissue sample from an infected patient to further demonstrate that the device could be used in the field.

The study, by Tsai TT et al, was published September 13, 2017, in the journal ACS Sensors.

Related Links:
National Taiwan University
Chang Gung Memorial Hospital

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Silver Member
Benchtop Image Acquisition Device
Microwell Imager
New
Vitamin B12 Test
CHORUS CLIA VIT B12

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.